Lack of Syndecan-1 promotes the pathogenesis of experimental rheumatoid arthritis
- PMID: 38451352
- DOI: 10.1007/s00251-024-01337-9
Lack of Syndecan-1 promotes the pathogenesis of experimental rheumatoid arthritis
Abstract
Syndecan-1 (Sdc-1), a transmembrane heparan sulfate protein, is implicated in several pathophysiological processes including rheumatoid arthritis (RA). The exact role of Syndican-1 in this autoimmune disease is still undetermined. This study explores the involvement level of Sdc-1 in the development of RA in a collagen II-induced arthritis mice model. RA was induced in two mice strains (wild-type BALB/c group and Sdc-1 knockout) by collagen II. Mice underwent regular clinical observations and scoring. After sacrifice, leg biopsies were taken from mice for histological examination, using a variety of stains. In addition, proteins were extracted, and molecular assessment of TNF-α was performed using the western blot technique. In the Sdc-1 knockout group, clinical scoring results showed a significantly more severe experimental RA; histology showed a significant increase in bone erosion, cartilage destruction, inflammation, and less granulated mast cells than the wild-type. In addition, molecular assessment of TNF-α showed more increase in expression in the Sdc-1 knockout models compared to the wild-type. Data suggest that lack of Sdc-1 enhances the inflammatory characteristics in RA. However, more molecular studies and investigations are needed to determine its exact role and possible mechanisms involved.
Keywords: Autoimmune diseases; Chronic inflammation; Rheumatoid arthritis; Syndecan-1.
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
References
-
- Agere SA, Kim EY, Akhtar N, Ahmed A (2018) Syndecans in chronic inflammatory and autoimmune diseases: pathological insights and therapeutic opportunities. J cell physiol. https://doi.org/10.1002/jcp.26388 - DOI - PubMed - PMC
-
- Day RM, Mitchell TJ, Knight SC, Forbes A (2003) Regulation of epithelial syndecan-1 expression by inflammatory cytokines. Cytokine 21:224–233. https://doi.org/10.1016/s1043-4666(03)00091-7 - DOI - PubMed
-
- Deyab G, Reine TM, Vuong TT et al (2021) Antirheumatic treatment is associated with reduced serum Syndecan-1 in rheumatoid arthritis. PLoS ONE 16:e0253247. https://doi.org/10.1371/journal.pone.0253247 - DOI - PubMed - PMC
-
- Fischer AH, Jacobson KA, Rose J, Zeller R (2018) CSH Protoc 2008:pdb-rot4986. https://doi.org/10.1101/pdb.prot4986 - DOI
-
- Furman D, Campisi J, Verdin E et al (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25:1822–1832. https://doi.org/10.1038/s41591-019-0675-0 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous
